Assignee
MYOVANT SCIENCES GMBH
CH·6 granted patents·2 pending applications·41 citations·filing 2019–2022
Top patents by PatentIndex Score
8 records- 0197US11583526B2Treatment of prostate cancerMYOVANT SCIENCES GMBH·Filed 2020·Granted Feb 21, 2023·9 cites·18 claims
- 0297US10449191B2Treatment of prostate cancerMYOVANT SCIENCES GMBH·Filed 2019·Granted Oct 22, 2019·13 cites·23 claims
- 0396US10786501B2Treatment of prostate cancerMYOVANT SCIENCES GMBH·Filed 2019·Granted Sep 29, 2020·12 cites·10 claims
- 0491US11033551B2Methods of treating uterine fibroidsMYOVANT SCIENCES GMBH·Filed 2019·Granted Jun 15, 2021·6 cites·26 claims
- 0576US11013780B2Methods of treating female infertilityMYOVANT SCIENCES GMBH·Filed 2019·Granted May 25, 2021·1 cites·17 claims
- 0673US2023045718A1Methods of increasing endogenous luteinizing hormoneMYOVANT SCIENCES GMBH·Filed 2022·Application pending·0 cites
- 0771US11638740B2Methods of treating female infertilityMYOVANT SCIENCES GMBH·Filed 2021·Granted May 2, 2023·0 cites·20 claims
- 0851US2022372044A1Crystalline solvated forms of n-(4-(1-(2,6-difluorobenzyl)-5- ((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4- tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-n'-methoxyureaMYOVANT SCIENCES GMBH·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →